Axsome Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Axsome Therapeutics, Inc.‘s stocks are currently a part of 122 hedge funds’ portfolios, which represents 29.87% of the total amount of its stocks outstanding. This makes up a total of 12.14M shares of Axsome Therapeutics, Inc.. Compared to the previous quarter, the number fell by -59.59% or -17.90M shares fewer. As for the holding position changes, 36.07% (44) of current hedge fund investors increased the number of shares held, 32.79% (40) of current holders sold a part of the shares held, and 15.57% (19) closed the holdings completely. 12 hedge funds are new holders of Axsome Therapeutics, Inc. stock in Q1 2023, it is 9.84% of total holders.
Hedge funds holding Axsome Therapeutics (Q2 2018 – Q1 2023)
| Q2 2018 | 35 |
|---|---|
| Q3 2018 | 33 |
| Q4 2018 | 35 |
| Q1 2019 | 65 |
| Q2 2019 | 106 |
| Q3 2019 | 111 |
| Q4 2019 | 168 |
| Q1 2020 | 163 |
| Q2 2020 | 188 |
| Q3 2020 | 171 |
| Q4 2020 | 177 |
| Q1 2021 | 183 |
| Q2 2021 | 174 |
| Q3 2021 | 166 |
| Q4 2021 | 163 |
| Q1 2022 | 171 |
| Q2 2022 | 164 |
| Q3 2022 | 181 |
| Q4 2022 | 215 |
| Q1 2023 | 122 |
Hedge funds changes in Axsome Therapeutics positions (Q2 2018 – Q1 2023)
| Q2 2018 | 5 | 8 | 6 | 5 | 11 |
|---|---|---|---|---|---|
| Q3 2018 | 6 | 6 | 9 | 8 | 4 |
| Q4 2018 | 12 | 4 | 10 | 9 | 0 |
| Q1 2019 | 38 | 13 | 9 | 9 | -4 |
| Q2 2019 | 54 | 25 | 20 | 13 | -6 |
| Q3 2019 | 24 | 45 | 24 | 19 | -1 |
| Q4 2019 | 69 | 41 | 49 | 12 | -3 |
| Q1 2020 | 45 | 63 | 41 | 46 | -32 |
| Q2 2020 | 56 | 67 | 47 | 30 | -12 |
| Q3 2020 | 21 | 47 | 71 | 37 | -5 |
| Q4 2020 | 22 | 66 | 58 | 16 | 15 |
| Q1 2021 | 35 | 64 | 51 | 28 | 5 |
| Q2 2021 | 23 | 67 | 50 | 31 | 3 |
| Q3 2021 | 32 | 67 | 39 | 38 | -10 |
| Q4 2021 | 21 | 51 | 57 | 25 | 9 |
| Q1 2022 | 32 | 42 | 61 | 22 | 14 |
| Q2 2022 | 25 | 66 | 42 | 29 | 2 |
| Q3 2022 | 45 | 64 | 47 | 23 | 2 |
| Q4 2022 | 60 | 59 | 72 | 24 | 0 |
| Q1 2023 | 12 | 44 | 40 | 19 | 7 |
Hedge funds changes in Axsome Therapeutics stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 55,000 | 145,000 |
|---|---|---|
| Q3 2018 | 16,000 | 9,000 |
| Q4 2018 | 284,000 | 63,000 |
| Q1 2019 | 25,435,000 | 8,803,000 |
| Q2 2019 | 28,497,000 | 10,877,000 |
| Q3 2019 | 29,392,000 | 16,198,000 |
| Q4 2019 | 250,673,000 | 126,169,000 |
| Q1 2020 | 106,717,000 | 73,415,000 |
| Q2 2020 | 51,689,992 | 69,041,000 |
| Q3 2020 | 44,460,000 | 66,171,000 |
| Q4 2020 | 49,911,000 | 55,251,000 |
| Q1 2021 | 14,119,000 | 53,590,000 |
| Q2 2021 | 28,358,000 | 60,380,000 |
| Q3 2021 | 48,971,000 | 57,345,000 |
| Q4 2021 | 140,557,000 | 49,949,000 |
| Q1 2022 | 94,934,000 | 64,843,000 |
| Q2 2022 | 102,677,000 | 109,815,000 |
| Q3 2022 | 113,571,000 | 113,340,000 |
| Q4 2022 | 178,960,724 | 132,779,934 |
| Q1 2023 | 5,143,918,000 | 3,705,329,000 |